US and Switzerland-based life science company 1Drop has raised $4.25m to expand the development of its portable diagnostic testing platform, which can analyse a drop of blood and deliver results in 15 minutes. The new device is designed for use by healthcare professionals who want to test patients on their own without having to travel to an emergency room. The series A funding was led by Swiss Startup Factory investor and former CVC Capital Partners partner Christian Wildmoser with support from fellow Swiss Startup investors Beat Schillig, Jean-Philippe de Toledo and VentureLab.
US and Switzerland-based life science company 1Drop has raised $4.25m to expand the development of its portable diagnostic testing platform, which can analyse a drop of blood and deliver results in 15 minutes. 1Drop is planning clinical tests and an application for regulatory approval, and is working with three pharmaceutical organisations to create similar diagnosis platforms for cardiology, autoimmune disease and glucose metabolism drug test candidates. The series A funding was led by Swiss Startup Factory investor and former CVC Capital Partners partner Christian Wildmoser with support from fellow Swiss Startup investors Beat Schillig, Jean-Philippe de Toledo and VentureLab.